Use of a Microfluidic Platform To Evaluate and Predict Reagent Performance in Microtiter Plate-Based Immunoassays

Area of Science:

• Biotechnology
• Immunology
• Assay Development

Background:

• Antibody selection and characterization are vital for robust immunoassays in vaccine development.
• Traditional methods like ELISA are resource-intensive and offer limited binding data.

Purpose of the Study:

• To evaluate the microfluidic Gyrolab system for comprehensive immunoassay reagent characterization.
• To compare Gyrolab performance against traditional ELISA for antibody assessment.

Main Methods:

• Applied microfluidic Gyrolab for holistic evaluation of immunoassay reagents.
• Analyzed concentration-response curves, antibody-antigen interactions, and estimated antibody affinity.
• Utilized a flexible, semi-universal assay format for "plug-and-play" comparisons.

Main Results:

• Gyrolab performance correlated well with traditional ELISA trends.
• Gyrolab provided additional data, including column images of antibody binding and affinity measurements.
• Automated Gyrolab system reduced time, reagent, and personnel requirements.

Conclusions:

• Microfluidic Gyrolab is an efficient and informative platform for antibody selection and characterization.
• Gyrolab offers advantages over plate-based ELISAs for immunoassay reagent evaluation.
• This method supports streamlined vaccine development by optimizing antibody assessment.